PMC full text:
Published online 2015 Jul 31. doi: 10.1371/journal.pone.0134021
Table 3
Prosthetic and native valve endocarditis—treatment and outomes.
| PVE | NVE | |||||
|---|---|---|---|---|---|---|
| Years | 1982–1987 | 1990–2003 | p | 1982–1987 | 1990–2003 | p |
| N | 75 | 75 | 75 | 75 | ||
| Medical | 38 (50.6%) | 24 (32%) | < 0.05 | 17 (22.7%) | 8 (10.7%) | NS |
| Death | 10 (26%) | 4 (16,6%) | NS | 6 (35%) | 1 (12.5%) | NS |
| Surgical | 37 (49.4%) | 51 (68%) | < 0.05 | 58 (77.3%) | 67 (89.3%) | NS |
| Death | 19 (51.3%) | 9 (17.6%) | < 0.01 | 8 (13.7%) | 2 (2.9%) | < 0.01 |
PVE—prosthetic valve endocarditis; NVE—native valve endocarditis; N—number; p—p value; NS—non significant.